Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov

American Heart Journal

Volumn 167, Issue 6, 2014, Pages

  Hill, Kevin D ^a,b   Chiswell, Karen ^b   Califf, Robert M ^a,b,c   Pearson, Gail ^d   Li, Jennifer S ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); DYSLIPIDEMIA; HEMATOLOGY; HUMAN; HYPERTENSION; INFECTION; MENTAL HEALTH; NATIONAL HEALTH ORGANIZATION; OBESITY; ONCOLOGY; PEDIATRIC CARDIOVASCULAR TRIAL; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DYSLIPIDEMIAS; FEDERAL GOVERNMENT; FINANCING, GOVERNMENT; HUMANS; HYPERTENSION; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; NATIONAL INSTITUTES OF HEALTH (U.S.); OBESITY; REGISTRIES; SAMPLE SIZE; UNITED STATES;

EID: 84901782473     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.02.002     Document Type: Article

References (24)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association Circulation 125 1 2012 e2 e220
2. J.M. Sorof, D. Lai, and J. Turner et al. Overweight, ethnicity, and the prevalence of hypertension in school-aged children Pediatrics 113 3 Pt 1 2004 475 482 (Pubitemid 38280786)
3. Improved national prevalence estimates for 18 selected major birth defects-United States, 1999-2001 MMWR Morb Mortal Wkly Rep 54 51 2006 1301 1305
4. Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects-United States, 2003 MMWR Morb Mortal Wkly Rep 56 2 2007 25 29
5. Fair tests of treatments in health care. The James Lind Library. http://www.jameslindlibrary.org. Accessed December 29, 2012.
6. J.T. Wilson An update on the therapeutic orphan Pediatrics 104 3 Pt 2 1999 585 590 (Pubitemid 29426624)
7. Food and Drug Administration. Status Report to Congress on the Pediatric Exclusivity Provision. 2001: http://www.fda.gov/downloads/drugs/ developmentapprovalprocess/developmentresources/ucm049915.pdf. Accessed December 29, 2012
8. M. Field, and T.F. Boat Safe and effective medicines for children. Pediatric studies conducted under the best pharmaceuticals for Children Act and the Pediatric Research Equity Act 1st ed. 2012 The National Academies Press Washington, DC
9. Full text of Best Pharmaceuticals for Children Act: http://www.fda.gov/ RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/ SignificantAmendmentstotheFDCAct/ucm148011.htm. Accessed December 29, 2012.
10. F.T. Bourgeois, S. Murthy, and C. Pinto et al. Pediatric versus adult drug trials for conditions with high pediatric disease burden Pediatrics 130 2 2012 285 292
11. S.K. Pasquali, W.K. Lam, and K. Chiswell et al. Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry Pediatrics 130 5 2012 e1269 e1277
12. D.A. Zarin, T. Tse, and R.J. Williams et al. The ClinicalTrials.gov results database - update and key issues N Engl J Med 364 9 2011 852 860
13. C. De Angelis, J.M. Drazen, and F.A. Frizelle et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors N Engl J Med 351 12 2004 1250 1251 (Pubitemid 39296312)
14. Full Text of Food and Drug Administration Amendments Act of 2007: http://www.fda.gov/RegulatoryInformation/Legislation/ FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/ FoodandDrugAdministrationAmendmentsActof2007/FullTextofFDAAALaw/default.htm. Accessed December 29, 2012.
15. A. Tasneem, L. Aberle, and H. Ananth et al. The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty PLoS One 7 3 2012 e33677
16. ClinicalTrials.gov Protocol Data Element Definitions: https://www.trialstransformation.org/ ctdotgov%20high%20level%20data%20dictionary%20V2.0.pdf. Accessed October 2, 2012.
17. R.M. Califf, D.A. Zarin, and J.M. Kramer et al. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010 JAMA 307 17 2012 1838 1847
18. J.S. Li, E.L. Eisenstein, and H.G. Grabowski et al. Economic return of clinical trials performed under the pediatric exclusivity program JAMA 297 5 2007 480 488 (Pubitemid 46220803)
19. List of dugs granted pediatric exclusivity: http://www.fda.gov/downloads/ Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM223058.pdf Accessed January 8, 2013.
20. Summary of NIH funding: http://report.nih.gov/budget-and-spending/index. aspx: Accessed January 8, 2013.
21. J.P. Ioannidis Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials JAMA 279 4 1998 281 286
22. M. Bhandari, J.W. Busse, and D. Jackowski et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials CMAJ 170 4 2004 477 480 (Pubitemid 38293642)
23. P.J. Easterbrook, J.A. Berlin, and R. Gopalan et al. Publication bias in clinical research Lancet 337 8746 1991 867 872
24. D.K. Benjamin Jr., P.B. Smith, and M.D. Murphy et al. Peer-reviewed publication of clinical trials completed for pediatric exclusivity JAMA 296 10 2006 1266 1273 (Pubitemid 44394898)